GRANTS

427 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

CREATE Bio Development Track: Preclinical and Early Phase Clinical Development for Biologics (U44 SBIR- Clinical Trial Optional)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: February 13, 2019, July 18, 2019, February 13, 2020, and July 20, 2020 , by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NINDS CREATE Bio Development Track: Preclinical Development for Biotechnology Products and Biologics (U01 - Clinical Trial Optional)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: February 13, 2019, July 18, 2019, February 13, 2020, and July 20, 2020), by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Basic and Translation Research on Decision Making in Aging and Alzheimer's Disease (R21 - Clinical Trial Optional)

Sponsor: National Institute on Aging

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: February 20, 2019; June 20, 2019; February 20, 2020; and June 22, 2020, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NeuroNEXT Clinical Trials (U01 - Clinical Trial Optional)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Institutional Training Programs to Advance Translational Research on Alzheimer's Disease and AD Related Dementias (T32 - Clinical Trial Not Allowed)

Sponsor: National Institute on Aging

Award: NIH intends to commit $2.5 million in fiscal year 2018 to fund three to five awards. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Sensory and motor system changes as predictors of preclinical Alzheimers disease (R01 - Clinical Trial Not Allowed)

Sponsor: National Institute on Aging

Award: NIA intends to commit $6 million in FY 2018 to fund eight to 10 awards.

Due Date: February 7, 2019; June 7, 2019; October 7, 2019; February 7, 2020; June 8, 2020; and October 8, 2020, by 5 p.m. local time of the applicant organization. Resubmission/Revision: July 7, 2018; November 7, 2018; March 7, 2019; July 8, 2019; November 7, 2019; March 6, 2020; July 7, 2020; and November 6, 2020, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Analytical Validation of Candidate Biomarkers for Neurological Disease (U01 Clinical Trial Optional)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: February, 14, 2019; July 18, 2019; February 14, 2020; and July 20, 2020, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: February 9, 2019, August 9, 2019, February 11, 2020, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed)

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for this FOA is February 25, 2018.

BRAIN Initiative: Biology and Biophysics of Neural Stimulation (R01 - Clinical Trials Optional)

Sponsor: National Institutes of Health

Award: NIH anticipates providing $5 million per year to fund an estimated five to 10 awards

Due Date: February 6, 2019, June 4, 2019, October 4, 2019, February 6, 2020, June 4, 2020, and October 6, 2020, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Current Filters

No filters selected

Filter By